Chile is tendering for radiopharmaceutical project in prostate cancer

The Chilean Nuclear Energy Commission (CCHEN) is formulating a research and development (R & D) project aimed at developing a radiopharmaceutical for the detection of prostate cancer.

The proposal, which will be presented to the Corfo Crea and Valida contest for its co-financing, allows for the intervention of an investor or collaborator entity that is involved in achieving the results of said project.

Review requirements and conditions here.

http://www.cchen.cl/wp-content/uploads/2019/01/Lllamado-a-presentar-declaraci%C3%B3n-de-interes_Corfo_2019-1.pdf

Arnaud Lefevre

Arnaud Lefevre

Arnaud Lefevre is the Chief Executive Officer of Dynatom International. Arnaud is in charge of the international development of the business portfolio.
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Don’t Stop Here

Russia is waiting for Uzbekistan

On the sidelines of the Russian Investment Forum in Sochi, the head of Rosatom, Alexey Likhachev Rosatom declared that Russia is still waiting for the

Scroll to Top